Malik, Bassit <br/><br/>
Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom.  [electronic resource] 

 -  British journal of haematology  03 2019 
 - 1040-1043 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.15234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Female<br/>Human T-lymphotropic virus 1--pathogenicity<br/>Humans<br/>Incidence<br/>Leukemia-Lymphoma, Adult T-Cell--diagnosis<br/>Prenatal Diagnosis--economics<br/>United Kingdom